HGYN

Hong Yuan Holding Group presently conducts no substantial business operations. Historically, the company's primary focus lay in the advancement and commercialization of bio-derived resins. It operated under the name Cereplast, Inc. until June 2021, when it officially adopted its current designation. Established in 2001, the entity's headquarters are situated in Zhengzhou, China.